The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×

Sections

Behavioral Treatment | Pharmacological Treatment | Conclusion | References

Excerpt

Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood. According to data from the Centers for Disease Control and Prevention (2010), an estimated 5.4 million U.S. children ages 4–17 years have ADHD, representing a prevalence of 9.5%. ADHD is conceptualized as developmentally inappropriate levels of inattention, hyperactivity, and/or impulsivity (see Box 4- for DSM-5 [American Psychiatric Association 2013] diagnostic criteria). These core symptoms result in functional impairments in multiple settings, thus impacting family, academic, and social arenas.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.
  • Institutional Login
  • Sign in via OpenAthens
  • Register for access
  • Please login/register if you wish to pair your device and check access availability.

    Not a subscriber?

    Subscribe Now / Learn More

    PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

    Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).